Sinoway Industrial Co., Ltd.

Octreotide Acetate 83150-76-9 Octreotide Acetate 83150-76-9

Octreotide Acetate 83150-76-9
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Octreotide Acetate 83150-76-9

  • Product name: Octreotide Acetate
  • CAS NO.: 83150-76-9
  • Molecular weight:1019.2393
  • Formula Weight: 1019.24
  • Molecular formula: C49H66N10O10S2
  • Packing: plastic vial (dedicated for peptide packing) or glass vial, quantity according to your detail requirement.
  • Storage: a cool (≤20 degree C) & dry place protected from light, keep package close when not in use.

Usage of Octreotide Acetate 83150-76-9

  • The Food and Drug Administration (FDA) has approved the usage of a salt form of this peptide, octreotide acetate, as an injectable depot formulation for the treatment of acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors (VIPomas).

MORE_DETAIL Octreotide Acetate 83150-76-9

Basic information of Octreotide Acetate 83150-76-9

  • Product name: Octreotide Acetate
  • CAS NO.: 83150-76-9
  • Molecular weight:1019.2393
  • Formula Weight: 1019.24
  • Molecular formula: C49H66N10O10S2
  • Packing: plastic vial (dedicated for peptide packing) or glass vial, quantity according to your detail requirement.
  • Storage: a cool (≤20 degree C) & dry place protected from light, keep package close when not in use.

Usage of Octreotide Acetate 83150-76-9

  • The Food and Drug Administration (FDA) has approved the usage of a salt form of this peptide, octreotide acetate, as an injectable depot formulation for the treatment of acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors (VIPomas).
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//